Co-Diagnostics Inc (CODX) Company Profile & Statistics

Co-Diagnostics Inc
CODX
(Nasdaq - US)
Open
1.21
+0.00 (0.00%)
in:usd•As of: Nov 04, 2024 15:59 UTC -5
Open
1.22
High
1.22
Low
1.21

About Co-Diagnostics Inc

CEO

Dwight Egan

Headquarters

2401 s. foothill drive, suite d

salt lake city, ut 84109, united states

Auditor

Haynie & Company

Employees

155

Share Holders

154

Website

www.codiagnostics.com

Industry

biotechnology

Sector

health technology

Company Overview

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.

Co-Diagnostics Inc Statistics

Valuation Measures

Market Capitalization ²	38.61M
Enterprise Value	24.75M
Enterprise Value/EBITDA (ttm)	-0.66
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.53
Price to Sales (ttm)	4.23
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	62.00%
Operating Margin (ttm)	-411.17%
Profit Margin (ttm)	-733.17%
Return on Equity (ttm)	-44.69%
Return on Invested Capital (ttm)	-45.46%
Return on Assets (ttm)	-40.47%

Income Statement

Revenue (ttm)	9.14M
Revenue Per Share (ttm)	0.29
Gross Profit (ttm)	5.47M
EBITDA (ttm)³	-37.42M
Net Income Avi to Common (ttm)	-37.57M
Diluted EPS (ttm)	-1.26

Share Statistics

Beta (5Y Monthly)	-0.84
52-Week Change	-0.82%
S&P500 52-Week Change	32.03%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	31.91M
Dividend Yield	0.00%
Float ⁴	29.96M
% Held by Insiders	6.10%
% Held by Institutions	14.99%

Balance Sheet

Total Cash (mrq)	44.88M
Total Cash Per Share (mrq)	1.41
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	9.09%
Quick Ratio (mrq)	8.81%
Book Value Per Share (mrq)	2.27

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.45
Free Cash Flow (ytd)	-14.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Co-Diagnostics Inc

Trade With A Regulated Broker